🔴 Live from the Global Virtual Conference on Shaping the Future of Malaria Research
Scientific Talk
Bickey Chang from the National Institute of Allergy and Infectious Diseases (NIAID)/The National Institutes of Health, USA, is presenting research at the 2026 Global Virtual Conference on Shaping the Future of Malaria Research.
Presentation Title: “The Monoclonal Antibody L9LS Is Safe and Efficacious Against Malaria in Infants but Interferes with the R21/Matrix-M Malaria Vaccine.”
The presentation examines the safety and efficacy of the monoclonal antibody L9LS against malaria in infants and its interaction with the R21/Matrix-M malaria vaccine.
The research provides insights into the use of monoclonal antibodies for malaria prevention and the interaction between L9LS and the R21/Matrix-M vaccine, contributing to the understanding of antibody-based and vaccine-based malaria prevention strategies.
Conference: MALARIA 2026 – Shaping the Future of Malaria Research
Speaker: Bickey Chang
Institution: National Institute of Allergy and Infectious Diseases (NIAID), NIH
Country: USA
Research Area: Malaria Prevention and Vaccine Research
Presentation: The Monoclonal Antibody L9LS Is Safe and Efficacious Against Malaria in Infants but Interferes with the R21/Matrix-M Malaria Vaccine
Date: June 29, 2026
Format: Online Conference
This conference is organized by Impact Research Communications (IRC)
More info: https://malaria.ircconferences.net/ | Global Malaria Research Initiative
